Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Miltenyi Biotec Acquires Owl Biomedical, Inc.

Published: Monday, April 29, 2013
Last Updated: Monday, April 29, 2013
Bookmark and Share
Microchip cell sorting technology broadens cell isolation capabilities.

Miltenyi Biotec announced that it has completed acquisition of Owl biomedical, Inc., an emerging company developing and commercializing microchip-based cell sorting systems using fully-closed disposable cartridges in an easy-to-use format. The acquisition underscores Miltenyi’s commitment to bringing comprehensive solutions to the research and clinical cell therapy markets. Financial terms of the acquisition were not disclosed.

“We are very pleased and proud to join Miltenyi Biotec, a proven leader in the development of research and cell therapy solutions,” said Dr. John Foster, president of Owl biomedical. “This acquisition combines Owl’s innovative microchip-based, high-speed cell sorting technology and intellectual property with Miltenyi Biotec’s strength in commercial design, manufacturing and marketing. This combination provides assurance that our technology will get to market in a timely manner with the highest quality engineering.”

Owl biomedical was founded in 2011 to develop and commercialize novel microchip-based cell sorting technology. The first product, The Nanosorter®, uses a closed fluid path cartridge that allows for “plug and play” cell sorting that avoids issues associated with traditional cell sorters. At the heart of the cartridge is a patented silicon microchip capable of extraordinarily high-frequency fluidic valving. The microchip is produced using high-performance semiconductor manufacturing technology which offers advantages in precision, production volume scalability and unprecedented overall performance in a cost effective manner. A major advancement of this approach is its capability to process samples from small to very large in an efficient and extremely gentle manner in a clean environment that is isolated from the laboratory setting.

“We immediately recognized the intrinsic value of Owl’s microchip-based technology for cell processing and its complement to our existing cell enrichment product portfolio,” said Stefan Miltenyi, founder and president, Miltenyi Biotec. “Miltenyi Biotec is committed to ensuring that our customers have access to such cutting-edge technologies to conduct cellular research and to translate their discoveries into important new cellular therapies.”

Miltenyi Biotec will announce more details around its plans to launch a cell purification platform employing the Owl biomedical capabilities before the end of 2013.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Toxicity Testing With Cultured Liver Cells
Microreactor replaces animal testing.
Study Validates Analysis of Copy Number Variation in Miniaturized Reaction Volumes
Data shows that accurate and reproducible CNV results can be produced with IntelliQube using the Array Tape® consumable.
Spotlight on Acoustic Liquid Handling
Journal of Laboratory Automation special issue highlights how acoustic liquid handling enables breakthrough innovations.
Organs on Chips
Combining 3D cell culture with microfluidics, organs-on-chips could revolutionize toxicology testing for pharmaceuticals, foods, cosmetics, pesticides, and industrial chemicals.
Finding the Needle in a Microbial Haystack
After developing a novel investigational technology called PathoChip that can rapidly identify elusive microorganisms, a team of Penn Medicine researchers recently succeeded for the first time in identifying a pathogen in a patient sample, demonstrating the proof of principle that this technology can be used to identify pathogens in human disease.
Organ-on-a-Chip
In a step toward personalized drug testing, researchers coax human stem cells to form complex tissues.
Diagnosing Cancer from a Single Drop of Blood
What if a physician could effectively diagnose cancer from one drop of a patient’s blood?
Study Reveals Shared Behavior of Microbes And Electrons
Bacteria streaming through a lattice behave like electrons in a magnetic material.
Study Reveals Shared Behavior of Microbes and Electrons
Bacteria streaming through a lattice behave like electrons in a magnetic material.
Detecting When and Why Deadly Blood Clots Form
New bioinspired blood coagulation assay is more sensitive than existing assays and could one day be used to diagnose rare bleeding disorders and prevent toxic effects of anticoagulant and antiplatelet drugs.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!